Rxo (RXO) Receivables - Net (2021 - 2026)

Rxo (RXO) has reported Receivables - Net for 6 consecutive years, with $1.2 billion the latest figure, recorded in Q1 2026.

• Receivables - Net for Q1 2026 came in at $1.2 billion, up 5.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 5.74% YoY), and the FY2025 annual result was $1.2 billion, changed 0.08% from the prior year.
• Receivables - Net was $1.2 billion for Q1 2026 at Rxo, down from $1.2 billion in the prior quarter.
• Over five years, Receivables - Net peaked at $1.2 billion in Q4 2024 and troughed at $716.0 million in Q1 2024.
• Average Receivables - Net over 5 years is $974.3 million, with a median of $1.0 billion recorded in 2022.
• Year-over-year, Receivables - Net decreased 22.23% in 2023 and soared 65.14% in 2024.
• Over 5 years, Receivables - Net stood at $900.0 million in 2022, then declined by 17.44% to $743.0 million in 2023, then jumped by 65.14% to $1.2 billion in 2024, then decreased by 0.08% to $1.2 billion in 2025, then retreated by 0.82% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.